RIGEL PHARMACEUTICALS, INC. (RIGL) Net margin 2016–2025
RIGEL PHARMACEUTICALS, INC. (RIGL) net profit margin by fiscal year — reported net income divided by reported revenue.
124.7%FY2025 · since FY2016: -339.6% → 124.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 124.7% | +115.0 pp |
| FY2024 | 9.8% | +31.2 pp |
| FY2023 | -21.5% | +27.2 pp |
| FY2022 | -48.7% | -36.7 pp |
| FY2021 | -12.0% | +15.4 pp |
| FY2020 | -27.4% | +85.4 pp |
| FY2019 | -112.8% | +45.5 pp |
| FY2018 | -158.3% | +1581.0 pp |
| FY2017 | -1739.3% | -1399.8 pp |
| FY2016 | -339.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More RIGL financial trends
RIGL RevenueRIGL Net incomeRIGL Gross profitRIGL Gross marginRIGL Operating incomeRIGL Operating marginRIGL Operating cash flowRIGL Free cash flowRIGL Capital expendituresRIGL Return on equityRIGL Stock buybacksRIGL Dividends paidRIGL Total assetsRIGL Total liabilitiesRIGL Shareholders’ equityRIGL overview →